ANDERSON MICHAEL SHANNON 4
4 · KV PHARMACEUTICAL CO /DE/ · Filed Jan 15, 2009
Insider Transaction Report
Form 4
KV PHARMACEUTICAL CO /DE/KVA / KVB
ANDERSON MICHAEL SHANNON
CEO, ETHEX Corporation
Transactions
- Award
Option to Purchase
2009-01-13+70,000→ 70,000 totalExercise: $2.95Exp: 2019-01-13→ Class A Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The option vests in three installments: 33% on January 13, 2010, 33% on January 13, 2011 and 34% on January 13, 2012.